MEF2C, a member of the MADS family of transcription factors, regulates hematopoietic self-renewal and differentiation, supports the proliferation of leukemias, and is associated with increased risk of relapse in leukemia patients as its phosphorylation leads to chemotherapy resistance (44). The gene discussed is MEF2C; the disease is leukemia.